Peptuvia

Tirzepatide vs Semaglutide

Semaglutide is the original single-target GLP-1 agonist, while tirzepatide adds GIP to the mix. The question researchers most often ask is what the second receptor (GIP) contributes on top of GLP-1 alone.

TirzepatideSemaglutide
Compound classDual GIP/GLP-1 receptor agonistGLP-1 receptor agonist
Primary targetGIP + GLP-1 receptorsGLP-1 receptor
CategoryGLP-1 & MetabolicGLP-1 & Metabolic
AdministrationWeekly subcutaneousWeekly subcutaneous
Research focusBody-composition & glycemic endpointsAppetite signaling & glycemic control

Key differences

  • Mechanism: semaglutide is a pure GLP-1 receptor agonist; tirzepatide co-activates GIP and GLP-1.
  • Effect size: head-to-head research generally reports larger body-composition and glycemic effects from tirzepatide's dual mechanism.
  • Dosing scale: semaglutide is dosed in fractions of a milligram weekly, whereas tirzepatide is dosed in whole milligrams weekly.
  • Track record: semaglutide has the longer history and broader dataset; tirzepatide is the more potent newer-generation molecule.

Which is right for your research?

Semaglutide is the reference GLP-1 compound and a sensible baseline; tirzepatide is the step up when the research question involves dual-incretin (GIP + GLP-1) activity. Both are weekly subcutaneous and titrate gradually.

Frequently asked questions

Is tirzepatide stronger than semaglutide?

In research comparisons, tirzepatide's dual GIP/GLP-1 mechanism is generally associated with larger metabolic and body-composition effects than semaglutide's single GLP-1 mechanism.

Do they use the same dosing units?

Both are dosed weekly, but semaglutide is measured in fractions of a milligram while tirzepatide is measured in whole milligrams.

What does GIP add over GLP-1?

GIP is a second incretin receptor. Co-activating it alongside GLP-1 is the mechanistic feature that distinguishes tirzepatide from a GLP-1-only compound like semaglutide.

For Research Use Only. All products are sold as research chemicals for in-vitro laboratory study. Not for human consumption, medical, veterinary, or household use.